━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
TECHNOLOGY TRANSFER PACKAGE
P-22 — GREEN
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

**ONE-LINE OPPORTUNITY**
Technology: Multi-segment shape-memory polymer catheter with autonomous navigation toward optimal drainage position. Problem: Suboptimal catheter placement = 3-5% of shunt failures. Repositioning requires surgery..

**BUYER PROBLEM**
Who: Catheter manufacturer / interventional device company
Problem: Suboptimal catheter placement = 3-5% of shunt failures. Repositioning requires surgery.
Current solution: Intraoperative placement (surgeon-dependent). Published steerable catheters use closed-loop control + sensing + passive safety (PubMed 25684857).
Why inadequate: Can a buckling-safe architecture with closed-loop control navigate safely without tissue damage?

**PROPOSED TECHNOLOGY**
Multi-segment shape-memory polymer catheter with autonomous navigation toward optimal drainage position

**WHY IT MAY MATTER**
Potential differentiation vs Intraoperative placement (surgeon-dependent). Published steerable catheters use : Can a buckling-safe architecture with closed-loop control navigate safely without tissue damage?

**CURRENT BEST ALTERNATIVE**
Intraoperative placement (surgeon-dependent). Published steerable catheters use closed-loop control + sensing + passive safety (PubMed 25684857).

**WHAT IS ACTUALLY DEMONSTRATED**

**WHAT IS ONLY MODELLED**
  - Actuation force (MODELLED)
  - Buckling limit (MODELLED, Euler)
  - Force margin (MODELLED, Stokes drag over-simplified)

**KNOWN FAILURES**
  - Buckling: catheter WILL buckle before reaching actuation force limit (82x exceedance)
  - Control stability NOT modeled (30s delay makes PID unstable)
  - Tissue safety: effective force 0.039 N exceeds estimated damage threshold 0.01 N by 4x
  - No failure recovery mechanism

**KEY DIFFERENTIATOR**
Potential differentiation vs Intraoperative placement (surgeon-dependent). Published steerable catheters use : Can a buckling-safe architecture with closed-loop control navigate safely without tissue damage?

**REMAINING DECISIVE UNCERTAINTY**
Can a buckling-safe architecture with closed-loop control navigate safely without tissue damage?

**DECISIVE EXPERIMENT**
Experiment: Bench: SMP catheter segment in tissue phantom. Measure: controlled navigation accuracy, buckling behavior, tissue contact force, failure recovery.
Pass: Safe closed-loop navigation to target within 5mm accuracy AND tissue force < 0.01 N AND failure recovery demonstrated
Fail: Buckling prevents controlled navigation OR tissue force > 0.01 N OR no failure recovery
Cost: $15-30K (ESTIMATED: SMP prototype + tissue phantom + force sensors)
Timeline: 8-12 weeks (ESTIMATED: prototype + testing)

**BUILD / INTEGRATION PATH**
VERY HIGH — SMP in CSF, control system, safety architecture

**REGULATORY STATUS**
PMA (active implantable with navigation) — very complex

**IP / DILIGENCE STATUS**
Known IP: BUYER_DILIGENCE_REQUIRED — no patent search performed for this package
Diligence required: Full freedom-to-operate analysis by buyer counsel

**COMMERCIAL ROUTES**
License to catheter/interventional company (HIGH RISK)
(Options: LICENSE | BUILD | ACQUIRE | CO-DEVELOP | COMMISSION_EXPERIMENT | INTEGRATE | REJECT)

**BUYER'S NEXT ACTION**
COMMISSION TEST — build SMP segment + tissue phantom, measure navigation + buckling + tissue force. CURRENT STATUS: HIGH-RISK CONTROL/SAFETY HYPOTHESIS

**EVIDENCE MANIFEST**
Evidence ledger hash: d0b47f61214570ae...
BUYER_ACTION_ID: P22-EXP-001

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━